Crossmark

Platelet protein biomarker panel for ovarian cancer diagnosis

Crossref DOI link: https://doi.org/10.1186/s40364-018-0118-y

Published Online: 2018-01-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lomnytska, Marta http://orcid.org/0000-0003-2773-8446
Pinto, Rui

Becker, Susanne

Engström, Ulla

Gustafsson, Sonja

Björklund, Christina

Templin, Markus

Bergstrand, Jan

Xu, Lei

Widengren, Jerker

Epstein, Elisabeth

Franzén, Bo

Auer, Gert
Funding

Funding for this research was provided by:

Stockholms Läns Landsting (HMT 20130704, HMT 20140754)

Karolinska Institutet (2013fobi37433)

Radiumhemmets Forskningsfonder (2016)

neoproteomics AB (2016)

Dagmar Ferbs Minnesfond (2012-2016)

VINNOVA (2014-03458)
More Information

Article History

Received: 5 September 2017

Accepted: 3 January 2018

First Online: 12 January 2018

Ethics approval and consent to participate

: Approval for the study was given by the local ethical committee of Stockholm County Council, Dnr 2010/504–31. Written consent for participation and data presentation was received from the patients who volunteered to take part in the study.

: Not applicable.

: Authors Gustafsson Sonja, Björklund Christina, Franzén Bo and Auer Gert are affiliated to NeoProteomics AB. Other authors declare no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.